Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarget Healthc. Regulatory News (THRL)

Share Price Information for Target Healthc. (THRL)

Share Price is delayed by 15 minutes
Get Live Data
110.60    -1.00 (-0.90%)
Bid:
110.40
Ask:
110.80
Spread: 0.40 (0.362%)
Market Cap: £685.98m
THRL Live PriceLast checked at - London Stock Exchange

Intraday Target Healthc. Share Chart

Holding(s) in Company

8 Oct 2025 16:08

RNS Number : 6174C
Target Healthcare REIT PLC
08 October 2025
Β 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BJGTLF51

Issuer Name

TARGET HEALTHCARE REIT PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Rathbones Investment Management Ltd

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

Name

City of registered office

Country of registered office

Rathbones Investment Management International Limited

St Helier

Jersey

4. Details of the shareholder

Name

City of registered office

Country of registered office

BNP Paribas Limited

London

United Kingdom

Rathbone Nominees Limited

London

United Kingdom

5. Date on which the threshold was crossed or reached

02-Oct-2025

6. Date on which Issuer notified

03-Oct-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.995500

0.000000

4.995500

30983995

Position of previous notification (if applicable)

8.087400

0.000000

8.087400

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BJGTLF51

30983995

4.995500

Sub Total 8.A

30983995

4.995500%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Β 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Β 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Rathbones Group Plc

Rathbones Investment Management Limited

4.778600

4.778600%

Rathbones Group Plc

Rathbones Investment Management International Limited

0.216900

0.216900%

10. In case of proxy voting

Name of the proxy holder

Β 

The number and % of voting rights held

Β 

The date until which the voting rights will be held

Β 

11. Additional Information

None

12. Date of Completion

03-Oct-2025

13. Place Of Completion

Port of Liverpool Building, Liverpool L3 1NW

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
HOLEASEPEEXSFFA
Date   Source Headline
19th Jun 202612:12 pmRNSHolding(s) in Company
6th May 20267:00 amRNSNet Asset Value, Corporate Update & Dividend
18th Mar 20267:00 amRNSHalf-year Report
16th Mar 202612:00 pmRNSInvestor Presentation via Investor Meet Company
16th Mar 202612:00 pmRNSInvestor Presentation via Investor Meet Company
12th Mar 20267:00 amRNSNotice of Half Year Results
24th Feb 20267:00 amRNSHolding(s) in Company
5th Feb 20267:00 amRNSNet Asset Value, Corporate Update & Dividend
24th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20257:00 amRNSResult of AGM
1st Dec 20257:00 amRNSAcquisition of care homes and forward commitment
4th Nov 20257:00 amRNSNet Asset Value, Corporate Update & Dividend
31st Oct 202510:00 amRNSAnnual Financial Report
17th Oct 20257:00 amRNSInvestor Presentation via Investor Meet Company
14th Oct 20257:00 amRNSFinal Results
8th Oct 20254:08 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSNotice of Full Year Results
25th Sep 20257:00 amRNSDisposal of homes, debt refinancing & pipeline
2nd Sep 20257:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSHolding(s) in Company
20th Aug 20254:42 pmRNSHolding(s) in Company
20th Aug 20257:00 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSNet Asset Value, Corporate Update & Dividend
30th Jul 202511:01 amRNSHolding(s) in Company
8th May 20257:00 amRNSNet Asset Value, Corporate Update & Dividend
10th Apr 20254:00 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSInvestor Presentation via Investor Meet Company
14th Mar 20257:00 amRNSHalf-year Report
11th Mar 20254:30 pmRNSNotice of Half Year Results
5th Mar 20257:00 amRNSAppointment of Joint Broker
3rd Mar 20254:20 pmRNSHolding(s) in Company
10th Feb 202511:21 amRNSHolding(s) in Company
5th Feb 20257:00 amRNSNet Asset Value, Corporate Update & Dividend
23rd Jan 20253:42 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSResult of AGM
29th Oct 20247:00 amRNSNet Asset Value, Corporate Update & Dividend
23rd Oct 202410:00 amRNSAnnual Financial Report
18th Sep 20247:00 amRNSInvestor Presentation via Investor Meet Company
17th Sep 20247:00 amRNSFinal Results
12th Sep 20249:00 amRNSNotice of Full Year Results
6th Aug 20247:00 amRNSNet Asset Value, Corporate Update & Dividend
27th Jun 20247:00 amRNSDisposal of four care homes for £44.5 million
20th May 202412:09 pmEQSEdison issues update on Target Healthcare REIT (THRL): Positive momentum continued in Q3
9th May 20247:00 amRNSNet Asset Value, Corporate Update & Dividend
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSHalf-year Report
8th Mar 20249:00 amRNSInvestor Presentation via Investor Meet Company
22nd Feb 20247:00 amRNSNotice of Half Year Results
6th Feb 20242:00 pmEQSEdison issues update on Target Healthcare REIT (THRL): Rent cover at a high and fully covered DPS
1st Feb 20247:00 amRNSNet Asset Value, Corporate Update & Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.